Together, these results implicate a CHK1/miRNA regulatory axis in radiation resistance in gastric cancer and support the utility of CHK1 as a predictive biomarker for radiotherapy response, potentially aiding in the stratification of patients for adjuvant treatment following surgery [115]. Here, CHEK1 is linked to gastric cancer.